Featured news
-
Addenbrooke's patient first in Europe to receive treatment for rare genetic disease
Mary Catchpole will be able to take one tablet twice a day to control the effects of her illness
-
Taking the fear out of Down Syndrome
When Sarah-Jane gave birth to Hannah with Down Syndrome, almost eight years ago, it was a shock for her and her husband, Sean, but now looking back it turned out to be less frightening than she first felt it would be.
-
Join our national Lunch & Learn series
Genomics is transforming healthcare - and it’s no longer a niche subject. From diagnosis to personalised treatment, genomic knowledge is becoming essential across all clinical roles.
-
Important change to requesting diagnostic cancer genetic testing (inherited cancers)
The eligibility criteria for diagnostic cancer genetic testing have significantly broadened in recent years, which has many benefits for patients and clinicians. But it also means that the East Anglia Clinical Genetics Service (CGS) no longer has the capacity to facilitate this type of test.
-
Rare Chromosome Disorder Awareness Day 2025
Rare Chromosome Disorder Awareness Day 2025 is being observed on Thursday, 19 June 2025, bringing together families, advocates, and healthcare professionals to highlight the unique challenges and remarkable resilience of those living with rare chromosome and gene disorders.
-
Improving efficiency and appropriateness of genomic test requests
To ensure that patients continue to benefit from genomic testing in the current context of increased NHS financial pressures, it is important for us all to work together to maximise benefits for patients.
All news
Showing 20 results
Call for wider genetic testing for children with brain tumours
A team of doctors at Addenbrooke’s have highlighted how a simple genetic screening test improved the diagnosis and treatment of a little 17-month old girl with a brain tumour – caused by a rare condition.
RAREfest 2022 at Cambrdige Guildhall Saturday 26 November
Will we see you there?
Public consultation on clinical genomics services in England
Consultation period update
Harnessing the power of genetic testing to improve patient care
The Norfolk and Norwich University Hospital is playing a vital role in the delivery of genomic testing across the East to tailor treatments for patients according to their genetic makeup.
Genetic test rules out cancer for baby Oliver
A baby who was born with a large tumour on his leg has been spared chemotherapy and surgery, after whole genome sequencing at Addenbrooke’s revealed the lump was harmless.
Sharing best practice in WGS for children with cancer
East Genomics together with Wellcome Connecting Science and the University of Cambridge are hosting this one day workshop in October.
Making a Difference: Genomics in Nursing and Midwifery Conference
A FREE conference aimed at nurses and midwives - across a wide range of roles and from 'ward to board' - working in the East Midlands or East of England. The conference will outline how genomics and genetic testing is helping patients in the East Midlands and East of England, the crucial role nurses and midwives are playing in embedding genomics into routine NHS care, and the role of East GMSA in supporting all of this.
Webinar: Harnessing the power of Clinical Nurse Specialists in the rollout of genomics
Organised by the East Genomic Medicine Service Alliance (GMSA) this webinar is aimed at clinical nurse specialists (CNSs) within Cambridge University Hospital NHS Foundation Trust (CUH), North West Anglia Foundation Trust, Royal Papworth Foundation Trust, Norfolk and Norwich NHS Foundation Trust (NNUH), James Paget Foundation Trust, Queen Elizabeth's Hospital King's Lynne Foundation Trust
New clues to treat germ cell tumours
A study by a team from Addenbrooke’s and the Wellcome Sanger Institute has revealed more about the origin of germ cell tumours, usually found in the ovaries and testicles, suggesting new approaches to future treatment.
Webinar: Lynch Syndrome Management
This webinar has been organised by the East Genomic Medicine Service Alliance (East GMSA). It is aimed at all clinicians, nurses, managers & coordinators in primary and secondary care who work with patients with Lynch Syndrome.
Rachel's story: Genomics helped me understand my cancer
Rachel Gilbert was diagnosed with gastrointestinal stromal tumours (GIST) aged 15 and says whole genome sequencing has provided vital answers for her and her family.
How is genomics changing pharmacy?
Genomics is starting to have a huge impact on pharmacy. Recently, genomics is being used to predict how an individual will handle specific drugs to reduce harm and improve outcomes.
Familial Cancer Specialists - a unique team supporting patients with suspected inherited cancer
Wendy Chorley is the Lead Familial Cancer Specialist at University Hospitals of Derby and Burton NHS Foundation Trust. She leads a team of five familial cancer specialists, most of whom are nurses or allied health professionals.
The role of genomics in midwifery
For Genomics Conversation Week 2022, Angela Crosby, Antenatal and Newborn Screening Coordinator, United Lincolnshire Hospitals NHS Trust (ULHT), talks about the role of her team and the impact genomics has in their work.
The importance of identifying patients with Monogenic Diabetes
For Diabetes Week (13 - 19 June), Anita Murphy, our regional Genetic Diabetes Nurse - East Midlands and East of England - has shared with us why it is important for clinicians to consider this type of diabetes when seeing patients and how it can change th
Nursing and midwifery team appointed to help peers across the region take a proactive role in genomic medicine
The recently appointed nursing and midwifery staff at East Genomics are an essential part of the strategic team to support the mainstreaming of genomic medicine into clinical practice across the East of England and East Midlands to help improve patient care and outcomes.
New genomic testing provides vital diagnosis for severely ill babies
Cambridge research suggests more than a third of severely sick babies given rapid whole genome sequencing have received a vital genetic diagnosis.
More than 100 children with cancer across the East of England benefit from whole genome sequencing
In a significant milestone, more than 100 children with cancer from across the East of England have had their tumours tested by whole genome sequencing (WGS) and interpreted by scientists in the NHS Genomic Medicine Service at Cambridge University Hospitals NHS Foundation Trust (CUH), to help improve their diagnosis and treatment.
Largest study of whole genome sequencing data reveals new causes of cancer
Cambridge analysis of more than 12,000 tumours from NHS patients has found DNA evidence of over 50 new potential causes of cancer.
Revolutionary new treatment path for patients with aggressive brain tumours
Brain tumour patients at Addenbrooke’s Hospital in Cambridge are the first in the UK to benefit from personalised treatment using the latest advances in genomics and targeted therapies through the Minderoo Foundation's new Precision Brain Tumour Programme (MPBTP).